Follow
Michael Keem
Michael Keem
Other namesMichael Hayden Keem, Michael H Keem
Unknown affiliation
Verified email at unimelb.edu.au
Title
Cited by
Cited by
Year
Barriers to women entering surgical careers: a global study into medical student perceptions
IH Marks, A Diaz, M Keem, SS Ladi-Seyedian, GS Philipo, H Munir, ...
World Journal of Surgery 44, 37-44, 2020
412020
Cerebrospinal fluid neurofilament light chain differentiates primary psychiatric disorders from rapidly progressive, Alzheimer's disease and frontotemporal disorders in …
D Eratne, SM Loi, QX Li, C Stehmann, CB Malpas, A Santillo, S Janelidze, ...
Alzheimer's & Dementia 18 (11), 2218-2233, 2022
272022
Cerebrospinal fluid neurofilament light chain differentiates behavioural variant frontotemporal dementia progressors from non-progressors
D Eratne, M Keem, C Lewis, M Kang, M Walterfang, S Farrand, S Loi, ...
Journal of the Neurological Sciences 442, 120439, 2022
112022
Plasma neurofilament light in behavioural variant frontotemporal dementia compared to mood and psychotic disorders
D Eratne, M Kang, C Malpas, S Simpson-Yap, C Lewis, C Dang, J Grewal, ...
Australian & New Zealand Journal of Psychiatry 58 (1), 70-81, 2024
102024
Assessment tools for complex post traumatic stress disorder: A systematic review
N Seiler, K Davoodi, M Keem, S Das
International Journal of Psychiatry in Clinical Practice 27 (3), 292-300, 2023
72023
Cerebrospinal fluid neurofilament light predicts longitudinal diagnostic change in patients with psychiatric and neurodegenerative disorders
MJY Kang, D Eratne, H Dobson, CB Malpas, M Keem, C Lewis, J Grewal, ...
Acta Neuropsychiatrica 36 (1), 17-28, 2024
62024
Prevalence of vitamin D deficiency among psychiatric inpatients: a systematic review
N Seiler, J Tsiglopoulos, M Keem, S Das, A Waterdrinker
International Journal of Psychiatry in Clinical Practice 26 (4), 330-336, 2022
52022
Cerebrospinal fluid neurofilament light improves accurate distinction between neurodegenerative and psychiatric disorders at a cognitive neuropsychiatry service
M Kang, D Eratne, H Dobson, CB Malpas, M Keem, C Lewis, J Grewal, ...
medRxiv, 2022.09. 08.22279663, 2022
12022
Do women and men experience similar barriers to surgical careers worldwide?
IH Marks, A Diaz, MH Keem, KM Daniels, SSSL Seyedian, E Fouda, ...
Journal of the American College of Surgeons 223 (4), S67-S68, 2016
12016
The Markers in Neuropsychiatric Disorders Study (The MiND Study): moving neurofilament light and other markers into the clinic to improve care for people with symptoms and …
D Eratne, C Lewis, M Kang, MH Keem, H Dobson, A Santillo, QX Li, ...
Alzheimer's & Dementia 19, e062655, 2023
2023
Role of neurofilament light chain to reduce diagnosis and improve outcomes for patients in a real‐world cognitive neuropsychiatry service: A retrospective MiND study
M Kang, D Eratne, H Dobson, MH Keem, QX Li, SM Loi, P Tsoukra, ...
Alzheimer's & Dementia 19, e064878, 2023
2023
Cerebrospinal fluid neurofilament light chain differentiates behavioural variant frontotemporal dementia progressors from ‘phenocopy’non‐progressors
MH Keem, D Eratne, C Lewis, M Kang, M Walterfang, SM Loi, W Kelso, ...
Alzheimer's & Dementia 18, e065333, 2022
2022
CEREBROSPINAL FLUID NEUROFILAMENT LIGHT CHAIN ASSISTS IN THE CHALLENGING DIFFERENTIATION OF PROGRESSIVE BEHAVIOURAL VARIANT FRONTOTEMPORAL DEMENTIA FROM'PHENOCOPY SYNDROME'
M Keem, QX Li, CL Masters, S Collins, A Santillo, D Velakoulis, D Eratne
AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY 56 (1_ SUPPL), 55-55, 2022
2022
BRINGING THE BENCH TO THE BEDSIDE: UPDATES ON THE MIND STUDY AND WHAT A ROUTINELY AVAILABLE SIMPLE BLOOD TEST FOR NEUROFILAMENT LIGHT WOULD MEAN AT THE CLINICAL COAL FACE FOR …
D Eratne, C Lewis, C Cadwallader, M Kang, M Keem, A Santillo, QX Li, ...
Deakin University, 2022
2022
HOT OFF THE PRESS: LATEST AND NOVEL FINDINGS OF BROAD MARKERS IN DIVERSE NEUROPSYCHIATRIC DISORDERS, LEVERAGING THE MIND STUDY'S DYNAMIC STUDY DESIGN AND SUPPORT OF SUBSTUDIES …
D Eratne, H Dobson, S Al Maawali, M Kang, M Keem, C Lewis, ...
Deakin University, 2022
2022
COULD CEREBROSPINAL FLUID NEUROFILAMENT LIGHT CHAIN REDUCE MISDIAGNOSIS IN NEURODEGENERATIVE AND NEUROPSYCHIATRIC DISORDERS? A RETROSPECTIVE CLINICAL AND DIAGNOSTIC UTILITY STUDY
M Kang, H Dobson, M Keem, QX Li, SM Loi, P Tsoukra, CL Masters, ...
AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY 56 (1_ SUPPL), 54-54, 2022
2022
The Markers in Neuropsychiatric Disorders Study (The MiND Study): moving neurofilament light and other markers into the clinic to improve care for people with symptoms and …
D Eratne, C Lewis, C Cadwallader, M Kang, M Keem, A Santillo, QX Li, ...
Deakin University, 2022
2022
Could cerebrospinal fluid neurofilament light chain reduce misdiagnosis in neurodegenerative and neuropsychiatric disorders in a real‐world setting? A retrospective clinical …
M Kang, H Dobson, QX Li, M Keem, SM Loi, CL Masters, S Collins, ...
Alzheimer's & Dementia 17, e058721, 2021
2021
Plasma neurofilament light chain and phosphorylated tau 181 in neurodegenerative and psychiatric disorders: moving closer towards a simple diagnostic test like a'C‐reactive …
D Eratne, A Santillo, QX Li, M Kang, M Keem, C Lewis, SM Loi, ...
Alzheimer's & Dementia 17, e058647, 2021
2021
The system can't perform the operation now. Try again later.
Articles 1–19